Predicting complication risks after sleeve lobectomy for non-small cell lung cancer
Translational Lung Cancer Research · 2024-06 · 13 (6) · 1318-1330
DOI: 10.21037/tlcr-24-325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Lung Cancer Research, 2024-06. Verfasst von Yiming He und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Sleeve lobectomy is a challenging procedure with a high risk of postoperative complications. To facilitate surgical decision-making and optimize perioperative treatment, we developed risk stratification models to quantify the probability of postoperative complications after sleeve lobectomy.
Methods
We retrospectively analyzed the clinical features of 691 non-small cell lung cancer (NSCLC) patients who underwent sleeve lobectomy between July 2016 and December 2019. Logistic regression models were trained and validated in the cohort to predict overall complications, major complications, and specific minor complications. The impact of specific complications in prognostic stratification was explored via the Kaplan-Meier method.
Results
Of 691 included patients, 232 (33.5%) developed complications, including 35 (5.1%) and 197 (28.5%) patients with major and minor complications, respectively. The models showed robust discrimination, yielding an area under the receiver operating characteristic (ROC) curve (AUC) of 0.853 [95% confidence interval (CI): 0.705-0.885] for predicting overall postoperative complication risk and 0.751 (95% CI: 0.727-0.762) specifically for major complication risks. Models predicting minor complications also achieved good performance, with AUCs ranging from 0.78 to 0.89. Survival analyses revealed a significant association between postoperative complications and poor prognosis.
Conclusions
Risk stratification models could accurately predict the probability and severity of complications in NSCLC patients following sleeve lobectomy, which may inform clinical decision-making for future patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Cardiothoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Thoracic Surgery Unit, Careggi University Hospital, Florence, Italy.
- Department of Thoracic & Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
ORCID-Profile: Lin Huang, René Horsleben Petersen
Zitieren
APA
He, Y., Huang, L., Deng, J., Zhong, Y., Chen, T., She, Y., Jiang, L., Zhao, D., Xie, D., Jiang, G., Bongiolatti, S., Antonoff, M. B., Petersen, R. H., & Chen, C. (2024). Predicting complication risks after sleeve lobectomy for non-small cell lung cancer. Translational Lung Cancer Research, 13(6), 1318-1330. https://doi.org/10.21037/tlcr-24-325
Vancouver
He Y, Huang L, Deng J, Zhong Y, Chen T, She Y, et al. Predicting complication risks after sleeve lobectomy for non-small cell lung cancer. Translational Lung Cancer Research. 2024;13(6):1318-1330. doi:10.21037/tlcr-24-325
BibTeX
@article{He2024,
author = {He, Yiming and Huang, Lin and Deng, Jiajun and Zhong, Yifan and Chen, Tao and She, Yunlang and Jiang, Lei and Zhao, Deping and Xie, Dong and Jiang, Gening and Bongiolatti, Stefano and Antonoff, Mara B and Petersen, René Horsleben and Chen, Chang},
title = {Predicting complication risks after sleeve lobectomy for non-small cell lung cancer},
journal = {Translational Lung Cancer Research},
year = {2024},
volume = {13},
number = {6},
pages = {1318--1330},
doi = {10.21037/tlcr-24-325}
}
EUVIMED